Detalhe da pesquisa
1.
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
Rheumatology (Oxford)
; 60(10): 4495-4507, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493312
2.
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
Ann Rheum Dis
; 79(10): 1340-1348, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699034
3.
Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial.
Ann Rheum Dis
; 77(1): 21-29, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507219
4.
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Ann Rheum Dis
; 74(6): 1110-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24834925
5.
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
Arthritis Rheumatol
; 73(3): 530-541, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32951358
6.
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
Arthritis Rheumatol
; 70(7): 1144-1154, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481737